Resultados da busca - Isidro Gonzáles
- Mostrando 1 - 10 resultados de 10
-
1
-
2
-
3
Neurocysticercosis por Héctor H. Garcı́a, Armando E. González, Silvia Rodríguez, Victor C. W. Tsang, E. Javier Pretell, Isidro Gonzáles, Robert H. Gilman
Publicado em 2010Artigo -
4
Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis por Héctor H. Garcı́a, Andrés G. Lescano, Isidro Gonzáles, Javier A. Bustos, E. Javier Pretell, John Horton, Herbert Saavedra, Armando E. González, Robert H. Gilman
Publicado em 2016Artigo -
5
Hippocampal Atrophy/Sclerosis Is Associated with Old, Calcified Parenchymal Brain Neurocysticercosis, But Not with More Recent, Viable Infections por Sofía S. Sánchez, Javier A. Bustos, Óscar H. Del Brutto, Genaro Herrera, Antônio Carlos dos Santos, E. Javier Pretell, Isidro Gonzáles, Herbert Saavedra, Héctor H. Garcı́a, _ _
Publicado em 2021Artigo -
6
Low sensitivity and frequent cross‐reactions in commercially available antibody detection <scp>ELISA</scp> assays for <i>Taenia solium</i> cysticercosis por Héctor H. Garcı́a, Yesenia Castillo, Isidro Gonzáles, Javier A. Bustos, Herbert Saavedra, Louis Jacob, Óscar H. Del Brutto, Patricia P. Wilkins, Armando E. González, Robert H. Gilman
Publicado em 2017Artigo -
7
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial por Héctor H. Garcı́a, Isidro Gonzáles, Andrés G. Lescano, Javier A. Bustos, Mirko Zimic, Diego Escalante, Herbert Saavedra, Martín Gavidia, L Rodríguez, Enrique Najar, Hugo Umeres, E. Javier Pretell
Publicado em 2014Artigo -
8
Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis por Héctor H. Garcı́a, Andrés G. Lescano, Vera Lúcia Lanchote, E. Javier Pretell, Isidro Gonzáles, Javier A. Bustos, Osvaldo Massaiti Takayanagui, Pierina Sueli Bonato, John Horton, Herbert Saavedra, Armando E. González, Robert H. Gilman
Publicado em 2011Artigo -
9
High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis por David Callacondo, H.H. García, Isidro Gonzáles, Diego Escalante, T E Nash, Robert H. Gilman, Victor C. W. Tsang, Armando E. González, María Teresa Rugeles López, César M. Gavidia, Manuel Martı́nez, Manuel Alvarado, Miguel A. Porras, Herbert Saavedra, Silvia Rodríguez, Manuela Verástegui, Holger Mayta, Genaro Herrera, Andrés G. Lescano, Mirko Zimic, Guillermo Gonzálvez, Luz M. Moyano, Viterbo Ayvar, Andre Diaz
Publicado em 2012Artigo -
10
Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis por Gianfranco Arroyo, Javier A. Bustos, Andrés G. Lescano, Isidro Gonzáles, Herbert Saavedra, Silvia Rodríguez, E. Javier Pretell, Pierina Sueli Bonato, Vera Lúcia Lanchote, Osvaldo Massaiti Takayanagui, John Horton, Armando E. González, Robert H. Gilman, Héctor H. Garcı́a, Victor C. W. Tsang, Seth E. O’Neal, Manuel Martı́nez, Mirko Zimic, Manuela Verástegui, Holger Mayta, Yesenia Castillo, María Teresa Rugeles López, César M. Gavidia, Luis A. Gómez-Puerta, Luz M. Moyano, Ricardo Gamboa, Percy Vilchez, Claudio Muro, Theodore E. Nash, Siddartha Mahanty, John Noh, Sukwan Handali, Jon S. Friedland
Publicado em 2019Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Pathology
Neurocysticercosis
Cysticercosis
Immunology
Psychiatry
Antiparasitic agent
Epilepsy
Internal medicine
Pharmacology
Surgery
Albendazole
Helminths
Praziquantel
Schistosomiasis
Pediatrics
Taenia solium
Antiparasitic
Carbamazepine
Concomitant
Gastroenterology
Pharmacokinetics
Alternative medicine
Anesthesia
Antibody
Atrophy
Basal (medicine)
Biology
Cerebrospinal fluid
Confidence interval